newsfilter
← Latest News
GlobeNewswire·

BioCryst Appoints David W. Jenkins as Chief Scientific Officer

RESEARCH TRIANGLE PARK, N.C., July 15, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) ("BioCryst" or the "Company") today announced the appointment of David W. Jenkins, MA, PhD,